About Oxymap
Oxymap is a Healthcare company based in Reykjavik (Iceland) founded in 2002. Retinal Imaging technology to assess retinal oxygen saturation and vessel width. Oxymap offers products and services including Oxymap T1. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Imaging.
Company details
A non-invasive imaging solution for retinal oxygen saturation and vessel width assessment was developed by Oxymap, founded in 2002 in Reykjavik, Iceland. The technology serves as an add-on to fundus cameras, enabling metabolic and structural retinal analysis for conditions like diabetic retinopathy and glaucoma. Spectral images are processed automatically by software to detect vessels and measure optical density, with the device holding CE marking in the medical imaging sector.
- Headquarters Reykjavik, Iceland
- SectorsHealthcare
- Website oxymap.com
- Social LinkedIn
- Latest Funding Round$55.01K (USD), Grant
Oct 2015
- InvestorsEuropean Union
& 1 more
Products & Services of Oxymap
Oxymap offers a comprehensive portfolio of products and services, including Oxymap T1.
Measures oxygen saturation in retinal blood vessels for disease diagnosis and monitoring.
Funding Insights of Oxymap
- Total Rounds 2
- Last Round Grant — $55,005
- First Round $56,000
(May 2015)
- Investors Count 2
All 2 funding rounds of Oxymap with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | $55,005 | Grant | – | – | |
| May 2015 | $56,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Oxymap
Oxymap has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Oxymap
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Oxymap
3 dated milestones of Oxymap across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Oxymap is founded.
- Funding First funding round of $56K.
- Funding Latest funding round, Grant, of $55K.
Web traffic of Oxymap
The website of Oxymap (oxymap.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 29.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oxymap
Oxymap was founded in 2002 and raised its 1st funding round 13 years after it was founded.
Oxymap is headquartered in Reykjavik, Iceland.
A non-invasive imaging solution for retinal oxygen saturation and vessel width assessment was developed by Oxymap, founded in 2002 in Reykjavik, Iceland. The technology serves as an add-on to fundus cameras, enabling metabolic and structural retinal analysis for conditions like diabetic retinopathy and glaucoma. Spectral images are processed automatically by software to detect vessels and measure optical density, with the device holding CE marking in the medical imaging sector.
Oxymap offers Oxymap T1.
Oxymap has 2 investors. Key investors include European Union, and EIC Fund.